Although not 'ideal', xenograft models of human hematopoiesis have proved to be extremely useful experimental systems for the study of the in vivo engraftment/proliferation potential of human hematopoietic stem/progenitor cells (HSC). Among these, the human/sheep xenograft model is unique in several respects. This model takes advantage of fetal immunologic immaturity and developing 'homing' spaces in the fetal bone marrow to obtain donor HSC engraftment in normal recipients without marrow conditioning. This avoids both the possible stromal abnormalities associated with irradiation- and/or chemotherapy-induced immunodeficiency which may limit human HSC engraftment or long-term maintenance of human hematopoiesis, and the use of genetically deficient hosts which may result in restricted donor cell expression. In the human/sheep xenograft model, human HSC (1) colonizes the bone marrow, (2) persists for many years, (3) is capable of multilineage differentiation, (4) retains its ability to respond to human cytokines, and (5) retains its ability to engraft/differentiate in secondary recipients. Another unique aspect of the sheep model is its large size; this permits repeated evaluation of human cell activity in the same chimeric sheep over long periods. The model appears to discriminate between the different populations of human HSC and exhibits a degree of sensitivity that suggests this in utero approach may serve as a biologically relevant model for the identification, characterization, and study of the in vivo potential of human HSC from available sources.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0925-5710(96)00445-8 | DOI Listing |
Nat Commun
January 2025
Epigenetics and Immune Disease Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Spain.
Dysregulated microglia activation, leading to neuroinflammation, is crucial in neurodegenerative disease development and progression. We constructed an atlas of human brain immune cells by integrating nineteen single-nucleus RNA-seq and single-cell RNA-seq datasets from multiple neurodegenerative conditions, comprising 241 samples from patients with Alzheimer's disease, autism spectrum disorder, epilepsy, multiple sclerosis, Lewy body diseases, COVID-19, and healthy controls. The integrated Human Microglia Atlas (HuMicA) included 90,716 nuclei/cells and revealed nine populations distributed across all conditions.
View Article and Find Full Text PDFBMJ Open
January 2025
Research, The University of Texas Health Science Center at Houston Cizik School of Nursing, Houston, Texas, USA.
Introduction: The annual prevalence of elder mistreatment (EM) in cognitively intact older adults is estimated to be 11%, yet the annual prevalence in older adults with Alzheimer's disease and related dementias (AD/ADRD) is estimated to be as high as 75%. Associated with a decrease in quality of life and increase in risk of mortality, EM represents a significant public health burden. Home-based primary care (HBPC) providers are uniquely positioned to address the critical need for robust EM screening and reporting, especially among individuals with AD/ADRD.
View Article and Find Full Text PDFBehav Ther
January 2025
McLean Hospital, Harvard Medical School, and University of Bergen.
Exposure and Response Prevention (ERP) is an effective treatment for obsessive-compulsive disorder (OCD), yet the specific underlying mechanisms by which ERP improves symptoms remain unclear. Initial theories suggested that habituation to triggering events and stimuli was the key therapeutic factor in ERP, while other theories highlight the role of developing the ability to tolerate distress, rather than reduction of distress. The current study examined improvements in distress tolerance as a mechanism of OCD, anxiety, and depressive symptom reductions during an ERP-based intensive program.
View Article and Find Full Text PDFJ Neurol
January 2025
Western Institute of Neuroscience, Western University, London, Canada.
Background: Repeat neurological assessment is standard in cases of severe acute brain injury. However, conventional measures rely on overt behavior. Unfortunately, behavioral responses may be difficult or impossible for some patients.
View Article and Find Full Text PDFJ Neurosci
January 2025
Department of Neuroscience, Rockefeller Neuroscience Institute, West Virginia University School of Medicine, Morgantown, WV, USA.
Synaptically released zinc is a neuronal signaling system that arises from the actions of the presynaptic vesicular zinc transporter protein ZnT3. Mechanisms that regulate the actions of zinc at synapses are of great importance for many aspects of synaptic signaling in the brain. Here, we identify the astrocytic zinc transporter protein ZIP12 as a candidate mechanism that contributes to zinc clearance at cortical synapses.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!